CA1194802A - Pharmaceutical composition possessing antitumor activity - Google Patents

Pharmaceutical composition possessing antitumor activity

Info

Publication number
CA1194802A
CA1194802A CA000413032A CA413032A CA1194802A CA 1194802 A CA1194802 A CA 1194802A CA 000413032 A CA000413032 A CA 000413032A CA 413032 A CA413032 A CA 413032A CA 1194802 A CA1194802 A CA 1194802A
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
pharmaceutical
tion
tumor
antitumor activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000413032A
Other languages
English (en)
French (fr)
Inventor
Inta Z. Lulle
Boris Z. Simkhovich
Aina A. Zidermane
Ruta A. Paegle
Margeris J. Lidak
Anatoly P. Gilev
Iya M. Kravchenko
Tamara I. Kagan
Petr A. Gembitsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INSTITUT ORGANICHESKOGO SINTEZA AKADEMII NAUK LATVIISKOI SSR
Original Assignee
INSTITUT ORGANICHESKOGO SINTEZA AKADEMII NAUK LATVIISKOI SSR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INSTITUT ORGANICHESKOGO SINTEZA AKADEMII NAUK LATVIISKOI SSR filed Critical INSTITUT ORGANICHESKOGO SINTEZA AKADEMII NAUK LATVIISKOI SSR
Application granted granted Critical
Publication of CA1194802A publication Critical patent/CA1194802A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA000413032A 1982-06-21 1982-10-07 Pharmaceutical composition possessing antitumor activity Expired CA1194802A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SU1982/000020 WO1984000105A1 (en) 1982-06-21 1982-06-21 Medicinal preparation having antitumoral effect

Publications (1)

Publication Number Publication Date
CA1194802A true CA1194802A (en) 1985-10-08

Family

ID=21616776

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000413032A Expired CA1194802A (en) 1982-06-21 1982-10-07 Pharmaceutical composition possessing antitumor activity

Country Status (9)

Country Link
JP (1) JPS59501110A (sv)
CA (1) CA1194802A (sv)
CH (1) CH660964A5 (sv)
DE (1) DE3249514T1 (sv)
FR (1) FR2535609A1 (sv)
GB (1) GB2134783B (sv)
NL (1) NL8220420A (sv)
SE (1) SE8400453L (sv)
WO (1) WO1984000105A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344846A (en) * 1992-12-30 1994-09-06 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for inhibiting deoxyhypusine synthase and the growth of cells
DE19628641C2 (de) * 1996-07-16 1998-12-17 Fresenius Ag Verwendung von PHMB zur Behandlung von Tumorerkrankungen
KR100557559B1 (ko) * 1999-12-20 2006-03-03 에스케이 주식회사 폴리헥사메틸렌구아니딘 인산염 분말, 이의 제조방법 및이를 함유한 항균수지
KR100725004B1 (ko) * 1999-12-24 2007-06-04 에스케이 주식회사 살균소독제 조성물 및 이의 사용방법
AT505312A1 (de) 2007-05-15 2008-12-15 Recticel Schlafkomfort Gmbh Sc Polyurethan-werkstoff mit einer bioziden ausrüstung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3824288A (en) * 1961-06-09 1974-07-16 Hoffmann La Roche Substituted hydrazine derivatives and process for the manufacture thereof
BR6457241D0 (pt) * 1963-12-23 1973-06-26 Rohm & Haas Processo para a preparacao de t-octil-guanidinas
GB1492678A (en) * 1975-08-11 1977-11-23 Ici Ltd Guanidine derivatives
JPS5341426A (en) * 1976-09-27 1978-04-14 Asahi Chem Ind Co Ltd Fungicidal and bactericidal agents

Also Published As

Publication number Publication date
GB2134783A (en) 1984-08-22
NL8220420A (nl) 1984-05-01
FR2535609A1 (fr) 1984-05-11
GB2134783B (en) 1985-10-30
DE3249514T1 (de) 1984-05-17
SE437931B (sv) 1985-03-25
SE8400453L (sv) 1985-03-25
FR2535609B1 (sv) 1985-03-15
CH660964A5 (de) 1987-06-30
WO1984000105A1 (en) 1984-01-19
SE8400453D0 (sv) 1984-01-30
JPS59501110A (ja) 1984-06-28
GB8403257D0 (en) 1984-03-14

Similar Documents

Publication Publication Date Title
CN111909155B (zh) 蛋白水解靶向嵌合体、提高其口服生物利用度的前药分子及应用
CN101254308B (zh) 甘草次酸-聚乙二醇/壳聚糖肝靶向复合给药系统及制备方法
US7169412B2 (en) Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
US6312734B1 (en) Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
Kovach et al. Toxicity and pharmacokinetics of a pyrrolizidine alkaloid, indicine N-oxide, in humans
US7371411B2 (en) Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
CA1194802A (en) Pharmaceutical composition possessing antitumor activity
Prakash et al. Cell-specific delivery of a transforming growth factor-beta type I receptor kinase inhibitor to proximal tubular cells for the treatment of renal fibrosis
KR20070094235A (ko) 킬레이팅 유기 고분자와 생물학적 금속으로 이루어진 나노입자, 그리고 ｅｐｒ 효과를 이용한 새로운 광범위 무독성항암제 및 그 제조 방법
AU2003251159B2 (en) Ruthenium anticancer complexes
KR100808630B1 (ko) 클로린 화합물을 포함하는 경구투여용 항종양 조성물
US5219846A (en) Treatment of human tumors utilizing compounds having a phosphoamides linkage or enol phosphate linkage
US20200330374A1 (en) Rectal mucosal administration preparation of pulsatilla chinensis saponin b4 and preparation method therefor
US20220387334A1 (en) Nanoparticles for preventing peri/post-menopausal bone loss and/or obesity
CN110183504A (zh) 一种具有肿瘤靶向性的吉西他滨前体药物及其制备方法和用途
Chen et al. A novel brain targeted 5-FU derivative with potential antitumor efficiency and decreased acute toxicity: synthesis, in vitro and in vivo evaluation
CN114028579A (zh) 核酸适配体-药物结合物PTK7-GEMs在制备治疗膀胱癌药物中的应用
JPH08310944A (ja) 肝疾患治療剤
CN106344930B (zh) 分子定点靶向和激活的短肽阿霉素的制备和用途
US20230391808A1 (en) Phosphaphenalene-gold(i) complexes as chemotherapeutic agents against glioblastoma
CN115611926B (zh) 非敏感键桥连的sn38二聚体前药及其自组装纳米粒和应用
WO2023088062A1 (zh) 厚朴酚和/或和厚朴酚芳环氨基取代类衍生物的抗低氧/缺氧损伤用途及药物组合物
Liao et al. Emodin induces osteosarcoma cell apoptosis by promoting ATM protein cleavage
CN100515461C (zh) 藤黄软膏制剂
Horn et al. Toxicity of the alkylating agent bendamustin

Legal Events

Date Code Title Description
MKEX Expiry